Digital Technologies

Here’s why the Cell and Gene Therapy Catapult is excited about the potential of digital twin technology.

Using AI to improve oncology care and find the right clinical trials for patients.

AI helps make preclinical decisions faster, but stakeholders remain cautious. We asked an expert from Elsevier for their views on the challenges.

New medicines save lives, but they take too long to get to market. Could AI make a difference?

Personalized medicine, digital therapeutics, and GLP-1s; experts tell us what areas are hot in pharma’s future.

AI solutions can help sift through clinical trial data for effective medical writing, but more people need to use it.

From wearable health tech to telehealth, here’s how digital transformation could impact the pharma industry and patient access.

A partnership between WhiteLab Genomics and Debiopharm will seek to use AI to streamline the development of targeted cancer therapies.

A Pistoia Alliance survey looks at stakeholder concerns in AI regulations, and calls for more harmonization and collaboration.

Takeda experts explore the potential of AI-driven drug discovery and the importance of including diverse patient voices in trial design.